Back to Search
Start Over
Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
- Source :
-
Neuropharmacology [Neuropharmacology] 2019 Nov 01; Vol. 158, pp. 107745. Date of Electronic Publication: 2019 Aug 21. - Publication Year :
- 2019
-
Abstract
- Non-competitive N-methyl-d-aspartate receptor antagonists mimic schizophrenia symptoms and produce immediate and persistent antidepressant effects. We investigated the effects of ketamine and phencyclidine (PCP) on thalamo-cortical network activity in awake, freely-moving male Wistar rats to gain new insight into the neuronal populations and brain circuits involved in the effects of NMDA-R antagonists. Single unit and local field potential (LFP) recordings were conducted in mediodorsal/centromedial thalamus and in medial prefrontal cortex (mPFC) using microelectrode arrays. Ketamine and PCP moderately increased the discharge rates of principal neurons in both areas while not attenuating the discharge of mPFC GABAergic interneurons. They also strongly affected LFP activity, reducing beta power and increasing that of gamma and high-frequency oscillation bands. These effects were short-lasting following the rapid pharmacokinetic profile of the drugs, and consequently were not present at 24 h after ketamine administration. The temporal profile of both drugs was remarkably different, with ketamine effects peaking earlier than PCP effects. Although this study is compatible with the glutamate hypothesis for fast-acting antidepressant action, it does not support a local disinhibition mechanism as the source for the increased pyramidal neuron activity in mPFC. The short-lasting increase in thalamo-cortical activity is likely associated with the rapid psychotomimetic action of both agents but could also be part of a cascade of events ultimately leading to the persistent antidepressant effects of ketamine. Changes in spectral contents of high-frequency bands by the drugs show potential as translational biomarkers for target engagement of NMDA-R modulators.<br /> (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Animals
GABAergic Neurons metabolism
Interneurons drug effects
Interneurons metabolism
Intralaminar Thalamic Nuclei cytology
Intralaminar Thalamic Nuclei metabolism
Mediodorsal Thalamic Nucleus cytology
Mediodorsal Thalamic Nucleus metabolism
Neurons drug effects
Neurons metabolism
Prefrontal Cortex cytology
Prefrontal Cortex metabolism
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
Thalamus
Wakefulness
Action Potentials drug effects
Excitatory Amino Acid Antagonists pharmacology
GABAergic Neurons drug effects
Intralaminar Thalamic Nuclei drug effects
Ketamine pharmacology
Mediodorsal Thalamic Nucleus drug effects
Phencyclidine pharmacology
Prefrontal Cortex drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7064
- Volume :
- 158
- Database :
- MEDLINE
- Journal :
- Neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31445017
- Full Text :
- https://doi.org/10.1016/j.neuropharm.2019.107745